{"entity":{"id":"tari-king","kind":"person","name":"Tari A. King","aka":[],"tldr":"Breast surgical oncologist at Winship Cancer Institute and President-Elect of the Society of Surgical Oncology, known for research on lobular breast cancer and surgical de-escalation.","summary":"Tari King is President-Elect of the Society of Surgical Oncology and a breast surgical oncologist at the Winship Cancer Institute of Emory University in Atlanta. Her research addresses invasive lobular carcinoma, ductal carcinoma in situ and the safe de-escalation of breast and axillary surgery. She has led national cooperative group studies in breast surgical oncology.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.surgonc.org/about-sso/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=King+TA%5BAuthor%5D+breast"}],"tags":["leadership","clinician-scientist","surgical oncology","breast cancer"],"related":[],"cancers":["breast-hr-positive","breast-her2-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sso"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"President-Elect","institutionId":"sso","specialisms":["Breast surgical oncology","Breast cancer","Lobular carcinoma"],"profiles":[{"label":"Society page","url":"https://www.surgonc.org/about-sso/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=King+TA%5BAuthor%5D+breast"}],"papers":[{"title":"Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy","journal":"Nature Reviews Clinical Oncology","year":2015,"doi":"10.1038/nrclinonc.2015.63"},{"title":"Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab","journal":"Cancer Discovery","year":2021,"doi":"10.1158/2159-8290.cd-20-1557"},{"title":"In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer","journal":"Nature Genetics","year":2015,"doi":"10.1038/ng.3391"}]},"route":"/people/tari-king/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"institution":[{"id":"sso","kind":"institution","name":"Society of Surgical Oncology","route":"/institutions/sso/"}]}}